IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Credits for the State of New Jersey

The listings below represent the applicants that are eligible for a Qualifying Therapeutic Discovery Program Credit.

The project descriptions below were extracted from the applicant certification forms as submitted. The list provides only the applicant name and amount of the credit for each project for which the disclosure of additional information was not authorized.

New Jersey $ 365,479.25
Applicant Name Project Name Eligible Credit Amount 2009 Eligible Credit Amount 2010
GENMAB INC Zanolimumab("HuMax-CD4) Treatment for a form of  Cancer, Cutaneous T-cell Lymphoma $ 244,479.25  
Orthogen LLC    $ 121,000.00  

 

Page Last Reviewed or Updated: 05-Jun-2014